Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ATRS

Antares Pharma (ATRS) Stock Price, News & Analysis

Antares Pharma logo

About Antares Pharma Stock (NASDAQ:ATRS)

Advanced Chart

Key Stats

Today's Range
$5.59
$5.59
50-Day Range
$5.59
$5.59
52-Week Range
$3.11
$5.60
Volume
6 shs
Average Volume
3.29 million shs
Market Capitalization
$955.06 million
P/E Ratio
23.29
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ATRS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Antares Pharma and its competitors with MarketBeat's FREE daily newsletter.

ATRS Stock News Headlines

Best Healthcare Penny Stocks
Antares Vision SpA AV
The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.
Antares Vision Share Price (AV.MI)
Antares Reaches New 52-Week High (AIS)
Antares Vision SpA (ANV)
COP Syringes Market Competitive Situation By 2030
See More Headlines

ATRS Stock Analysis - Frequently Asked Questions

Antares Pharma, Inc. (NASDAQ:ATRS) issued its quarterly earnings data on Thursday, November, 4th. The specialty pharmaceutical company reported $0.03 earnings per share for the quarter, hitting the consensus estimate of $0.03. The specialty pharmaceutical company earned $48.19 million during the quarter, compared to the consensus estimate of $48.52 million. Antares Pharma had a net margin of 21.90% and a trailing twelve-month return on equity of 7.43%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Antares Pharma investors own include Ballard Power Systems (BLDP), Advanced Micro Devices (AMD), Novavax (NVAX), NVIDIA (NVDA), Micron Technology (MU), Meta Platforms (META) and Prospect Capital (PSEC).

Company Calendar

Last Earnings
11/04/2021
Today
7/10/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & Medical Instruments
Sub-Industry
Health Care Supplies
Current Symbol
NASDAQ:ATRS
CIK
1016169
Employees
201
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
$0.24
Trailing P/E Ratio
23.29
Forward P/E Ratio
69.88
P/E Growth
N/A
Net Income
$46.29 million
Net Margins
21.90%
Pretax Margin
29.84%
Return on Equity
7.43%
Return on Assets
4.92%

Debt

Debt-to-Equity Ratio
0.10
Current Ratio
3.08
Quick Ratio
2.87

Sales & Book Value

Annual Sales
$183.98 million
Price / Sales
5.19
Cash Flow
$0.13 per share
Price / Cash Flow
43.89
Book Value
$1.03 per share
Price / Book
5.43

Miscellaneous

Outstanding Shares
170,852,000
Free Float
160,772,000
Market Cap
$955.06 million
Optionable
Optionable
Beta
1.15

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:ATRS) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners